Land: USA
Språk: engelska
Källa: NLM (National Library of Medicine)
TOPIRAMATE (UNII: 0H73WJJ391) (TOPIRAMATE - UNII:0H73WJJ391)
REMEDYREPACK INC.
ORAL
PRESCRIPTION DRUG
TOPAMAX ® is indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older. TOPAMAX ® is indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older. TOPAMAX ® is indicated for the preventive treatment of migraine in patients 12 years of age and older. None. Pregnancy Exposure Registry There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to TOPAMAX ® during pregnancy. Patients should be encouraged to enroll in the North American Antiepileptic Drug (NAAED) Pregnancy Registry if they become pregnant. This registry is collecting information about the safety of antiepileptic drugs during pregnancy. To enroll, patients can call the toll-free number 1-888-233-2334. Information about the North American Drug Pregnancy Registry can be found at h
TOPAMAX ® Tablets TOPAMAX ® (topiramate) Tablets are available as debossed, coated, round tablets in the following strengths and colors: TOPAMAX ® Sprinkle Capsules TOPAMAX ® (topiramate capsules) Sprinkle Capsules contain small, white to off-white spheres. The gelatin capsules are white and clear and are marked as follows: TOPAMAX ® Tablets TOPAMAX ® Tablets should be stored in tightly-closed containers at controlled room temperature (59° to 86°F, 15° to 30°C). Protect from moisture. TOPAMAX ® Sprinkle Capsules TOPAMAX ® Sprinkle Capsules should be stored in tightly-closed containers at or below 25°C (77°F). Protect from moisture.
New Drug Application
REMEDYREPACK INC. ---------- This Medication Guide has been approved by the U.S. Food and Drug Administration Revised:12/2018 MEDICATION GUIDE TOPAMAX ® (TOE-PA-MAX) (topiramate) TABLETS, for oral use TOPAMAX ® (TOE-PA-MAX) (topiramate capsules) SPRINKLE CAPSULES, for oral use What is the most important information I should know about TOPAMAX? TOPAMAX may cause eye problems. Serious eye problems include: • any sudden decrease in vision with or without eye pain and redness. • a blockage of fluid in the eye causing increased pressure in the eye (secondary angle closure glaucoma). • These eye problems can lead to permanent loss of vision if not treated. • You should call your healthcare provider right away if you have any new eye symptoms, including any new problems with your vision. TOPAMAX may cause decreased sweating and increased body temperature (fever). People, especially children, should be watched for signs of decreased sweating and fever, especially in hot temperatures. Some people may need to be hospitalized for this condition. If a high fever, a fever that does not go away, or decreased sweating develops, call your healthcare provider right away. TOPAMAX can increase the level of acid in your blood (metabolic acidosis). If left untreated, metabolic acidosis can cause brittle or soft bones (osteoporosis, osteomalacia, osteopenia), kidney stones, can slow the rate of growth in children, and may possibly harm your baby if you are pregnant. Metabolic acidosis can happen with or without symptoms. Sometimes people with metabolic acidosis will: • feel tired • not feel hungry (loss of appetite) • feel changes in heartbeat • have trouble thinking clearly Your healthcare provider should do a blood test to measure the level of acid in your blood before and during your treatment with TOPAMAX. If you are pregnant, you should talk to your healthcare provider about whether you have metabolic acidosis. Like other antiepileptic drugs, TOPAMAX may cause suicidal thoughts or actions in a very small number Läs hela dokumentet
TOPAMAX- TOPIRAMATE TABLET, COATED REMEDYREPACK INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE TOPAMAX SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR TOPAMAX TOPAMAX (TOPIRAMATE) TABLETS, FOR ORAL USE TOPAMAX (TOPIRAMATE CAPSULES) SPRINKLE CAPSULES, FOR ORAL USE INITIAL U.S. APPROVAL: 1996 INDICATIONS AND USAGE TOPAMAX is indicated for: Epilepsy: initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older ( 1.1); adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic- clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older ( 1.2) Preventive treatment of migraine in patients 12 years of age and older ( 1.3) DOSAGE AND ADMINISTRATION TOPAMAX initial dose, titration, and recommended maintenance dose varies by indication and age group. See Full Prescribing Information for recommended dosage, and dosing considerations in patients with renal impairment, geriatric patients, and patients undergoing hemodialysis ( 2.1, 2.2, 2.3, 2.4, 2.5, 2.6) DOSAGE FORMS AND STRENGTHS Tablets: 25 mg, 50 mg, 100 mg, and 200 mg ( 3) Sprinkle Capsules: 15 mg and 25 mg ( 3) CONTRAINDICATIONS None ( 4) WARNINGS AND PRECAUTIONS Acute myopia and secondary angle closure glaucoma: can lead to permanent visual loss; discontinue TOPAMAX as soon as possible ( 5.1) Visual field defects: consider discontinuation of TOPAMAX ( 5.2) Oligohidrosis and hyperthermia: monitor decreased sweating and increased body temperature, especially in pediatric patients ( 5.3) Metabolic acidosis: baseline and periodic measurement of serum bicarbonate is recommended; consider dose reduction or discontinuation of TOPAMAX if clinically appropriate ( 5.4) Suicidal behavior and ideation: antiepileptic drugs increase the risk of suicidal behavior or ideation ( 5.5) Cognitive/neuropsychiatric adverse reactions: use caution when ope Läs hela dokumentet